EP
VCYT icon

Essential Partners’s Veracyte VCYT Stock Holding History

Essential Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$230 Hold
5
– – ﹤0.01% 2568
2026
Q2 		$294 Buy
5
+4
+400% +$168 ﹤0.01% 2569
2026
Q1 		$32 Buy
+1
New +$37 ﹤0.01% 2805

Other funds holding VCYT

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Essential Partners's VCYT Position: Q3 2026 in Review

Essential Partners held its Veracyte (VCYT) position steady in Q3 2026 at 5 shares worth $230. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

Essential Partners first reported a position in VCYT in Q1 2026 and has held it in 3 quarters since. The position peaked at $294 in Q2 2026. 24 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Essential Partners held 5 shares of Veracyte worth $230 as of Q3 2026.
  • Essential Partners left its Veracyte share count unchanged in Q3 2026.
  • Veracyte made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2568 holding.
  • Essential Partners first reported a position in Veracyte in Q1 2026 and has held it in 3 quarters since.
  • Essential Partners's Veracyte position peaked at $294 in Q2 2026.
  • 24 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.